SHOCKING: Indivior | Mind Blowing Facts

Australia To Lose Life-Saving Opioid Drug As Trump Administration Pricing Changes Ripple Worldwide

Australia will lose access to the life-saving opioid treatment Sublocade as experts warn global drug pricing pressures and US policy changes could threaten more medicines.

International Business Times UK · Jul 1

‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year

Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration

The Guardian - AU · Jul 1

This common antidepressant helps people cut back on methamphetamine – new study

Methamphetamine – more commonly known as meth, crystal or ice – is a highly addictive, stimulant drug.

The Conversation · Apr 1

Drugmaker Indivior to abandon London listing amid exodus of companies

Firm behind opioid addiction treatment drugs quits London Stock Exchange after moving primary to US last year

The Guardian - UK · Jun 2, 2025

Drug maker Indivior to abandon London stock market for the US

Indivior’s exit comes after the company moved its primary listing to the US’s Nasdaq index last year.

Evening Standard · Jun 2, 2025

Drug maker Indivior joins the flight from London share listings

Pharmaceuticals company said most of its product sales and shareholders are US based

Evening Standard · Jun 2, 2025

Flutter shareholders vote to move listing from London to New York

Paddy Power owner will make switch to its ‘natural home’ by May in further blow to London Stock Exchange

The Guardian - UK · May 1, 2024

Drug firm Indivior plans to move primary listing to US in snub to London

Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui

The Guardian - UK · Feb 22, 2024

UK borrowing costs hit new 25-year high; Chinese stocks fall to pre-pandemic level – as it happened

Rolling, live coverage of business, economics and financial markets as British bond yields rise amid expectations of stubbornly high interest rates

The Guardian - UK · Oct 23, 2023

Maker of anti-addiction drug Suboxone reaches $102.5 million settlement over antitrust claims

The company that makes the opioid addiction treatment drug Suboxone has reached a $102.5 million settlement of antitrust claims with 41 states and the District of Columbia

The Independent UK · Jun 2, 2023